Keywords: Pfizer, Filiburvir, Hepatitis C, Sanofi, Plavix, Justice Dept, USA, AbbVie, InterMune, EMA, Injunction, Clinical trial transparency

News briefs: Pfizer's filiburvir; Sanofi's Plavix; EMA sued over transparency

Article | 11 March 2013

Print This

Among a batch of news reported over the weekend, US drugs behemoth Pfizer (NYSE: PFE) has halted development of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in